Vytrus Biotech S.A [VYT] vs Biotechnology Assets [BST] Detailed Stock Comparison

Vytrus Biotech S.A.

BME
Loading...

Biotechnology Assets S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Vytrus Biotech S.A. wins in 12 metrics, Biotechnology Assets S.A. wins in 4 metrics, with 0 ties. Vytrus Biotech S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vytrus Biotech S.A. Biotechnology Assets S.A. Better
P/E Ratio (TTM) 49.36 10.77 Biotechnology Assets S.A.
Price-to-Book Ratio 19.87 2.60 Biotechnology Assets S.A.
Debt-to-Equity Ratio 12.03 33.82 Vytrus Biotech S.A.
PEG Ratio 32.43 N/A N/A
EV/EBITDA 41.45 -13.27 Vytrus Biotech S.A.
Profit Margin (TTM) 29.89% -68.10% Vytrus Biotech S.A.
Operating Margin (TTM) 32.87% -85.89% Vytrus Biotech S.A.
EBITDA Margin (TTM) 32.87% N/A N/A
Return on Equity 32.92% -30.40% Vytrus Biotech S.A.
Return on Assets (TTM) 15.29% -7.67% Vytrus Biotech S.A.
Free Cash Flow (TTM) $1.22M $-794,574 Vytrus Biotech S.A.
1-Year Return 512.50% -16.13% Vytrus Biotech S.A.
Price-to-Sales Ratio (TTM) 14.93 6.32 Biotechnology Assets S.A.
Enterprise Value $140.61M $18.72M Vytrus Biotech S.A.
EV/Revenue Ratio 14.51 6.13 Biotechnology Assets S.A.
Revenue per Share (TTM) $1 $0 Vytrus Biotech S.A.
Earnings per Share (Diluted) $0.39 $-0.03 Vytrus Biotech S.A.
Beta (Stock Volatility) -0.14 1.78 Vytrus Biotech S.A.

Vytrus Biotech S.A. vs Biotechnology Assets S.A. Stock Performance Analysis

Loading Price Chart...

VYT
BST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vytrus Biotech S.A.1.82%11.05%29.80%115.38%206.25%134.73%
Biotechnology Assets S.A.0.00%8.33%13.04%30.00%-27.78%30.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vytrus Biotech S.A.512.50%497.56%595.04%595.04%595.04%595.04%
Biotechnology Assets S.A.-16.13%-21.21%-70.79%-91.88%-88.50%-88.50%

Performance & Financial Health Analysis: Vytrus Biotech S.A. vs Biotechnology Assets S.A.

MetricVYTBST
Market Information
Market Cap i€144.69M€19.30M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i15,974226,591
90 Day Avg. Volume i14,159275,900
Last Close€19.60€0.26
52 Week Range€3.04 - €20.60€0.18 - €0.49
% from 52W High-4.85%-46.83%
All-Time High€20.60 (Apr 14, 2026)€13.98 (Jun 23, 2014)
% from All-Time High-4.85%-98.14%
Growth Metrics
Quarterly Revenue Growth0.53%0.08%
Quarterly Earnings Growth1.85%N/A
Financial Health
Profit Margin (TTM) i0.30%-0.68%
Operating Margin (TTM) i0.33%-0.86%
Return on Equity (TTM) i0.33%-0.30%
Debt to Equity (MRQ) i12.0333.82
Cash & Liquidity
Book Value per Share (MRQ)€0.97€0.10
Cash per Share (MRQ)€0.46€0.01
Operating Cash Flow (TTM) i€3.90M€574,211
Levered Free Cash Flow (TTM) i€76,132€-329,133
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Vytrus Biotech S.A. vs Biotechnology Assets S.A.

MetricVYT (Apr 24, 2026)BST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i49.3610.77
Forward P/E i32.43N/A
PEG Ratio i32.43N/A
Price to Sales (TTM) i14.936.32
Price to Book (MRQ) i19.872.60
Market Capitalization
Market Capitalization i€144.69M€19.30M
Enterprise Value i€140.61M€18.72M
Enterprise Value Metrics
Enterprise to Revenue i14.516.13
Enterprise to EBITDA i41.45-13.27
Risk & Other Metrics
Beta i-0.141.78
Book Value per Share (MRQ) i€0.97€0.10

Financial Statements Comparison: Vytrus Biotech S.A. vs Biotechnology Assets S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVYT (2025)BST (2024)
Revenue/Sales i8.37M2.51M
Cost of Goods Sold i-457,321-138,410
COGS % of Revenue i-5.5%-5.5%
Gross Profit i8.83M2.65M
Gross Margin i105.5%105.5%
Research & Development iN/A0
Operating Income (EBIT) i3.18M-2.22M
Operating Margin i38.0%-88.1%
EBITDA i4.16M-110,145
EBITDA Margin i49.7%-4.4%
Pre-Tax Income i3.13M-3.06M
Pre-Tax Income % of Revenue i37.3%-121.5%
Income Tax i229,300-139,119
Income Tax % of Revenue i2.7%-5.5%
Net Income (Profit) i2.90M-2.92M
Profit Margin i34.6%-116.0%

Balance Sheet & Liquidity Metrics

MetricVYT (2025)BST (2024)
Cash & Equivalents i3.38M143,822
Total Current Assets i5.39M3.70M
Total Current Assets % of Revenue i64.4%147.1%
Total Current Liabilities i1.78M4.55M
Total Current Liabilities % of Revenue i21.2%180.9%
Long-Term Debt i1.54M2.39M
Long-Term Debt % of Revenue i18.4%95.0%
Total Shareholders Equity i10.31M6.61M
Retained Earnings i2.90M-23.57M
Retained Earnings % of Revenue i34.6%-937.2%
Property, Plant & Equipment i773,343481,199

Cash Flow Statement Comparison

MetricVYT (2025)BST (2024)
Operating Cash Flow i2.38M-3.00M
Operating Cash Flow % of Revenue i28.4%-119.3%
Capital Expenditures i-1.01M-13,765
Free Cash Flow i1.22M-794,574
FCF Margin i14.6%-31.6%
Debt Repayment i-645,777-1.65M
Common Stock Repurchase i-867,374-120,525

Short Interest & Institutional Ownership Analysis

MetricVYTBST
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i7.52M68.09M
Float Shares iN/AN/A
% Held by Insiders i64.89%45.27%
% Held by Institutions i0.35%0.10%
% Held by Public i34.76%54.63%

Dividend Analysis & Yield Comparison: Vytrus Biotech S.A. vs Biotechnology Assets S.A.

MetricVYTBST
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A